RGLS

Regulus Therapeutics
RGLS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

50 hedge funds and large institutions have $38.1M invested in Regulus Therapeutics in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

34% less capital invested

Capital invested by funds: $58.1M → $38.1M (-$20M)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$232K
2
+$147K
3
+$121K
4
VF
Virtu Financial
New York
+$56K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$26.8K

Top Sellers

1
-$1.57M
2
-$408K
3
-$360K
4
Victory Capital Management
Victory Capital Management
Texas
-$341K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$39K
27
$24K
28
$19K
29
$16K
30
$16K
31
$14K
32
$14K
33
$11K
34
$10K
35
$9K
36
$9K
37
$7K
38
$6K
39
$5K
40
$4K
41
$4K
42
$3K
43
$3K
44
$1.44K
45
$1K
46
$1K
47
$144
48
$3
49
–
50
–
1
2
3